Attenuated rubella virus vaccine in women. Clinical trials during the postpartum period.
D000328:Adult; D000906:Antibodies / Q000032:analysis; D002986:Clinical Trials as Topic; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007223:Infant; D008431:Maternal-Fetal Exchange; D008722:Methods; D009437:Neuralgia / Q000209:etiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D012409:Rubella / Q000276:immunology* / Q000517:prevention & control; D012411:Rubella Vaccine; D012412:Rubella virus; D014611:Vaccination; D014765:Viral Vaccines
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines